|
David Southwell is a member of the Audit Committee. Until recently Mr. Southwell was at Sepracor Inc. a research-based pharmaceutical company where he served as Executive Vice President and Chief Financial Officer and also had responsibility for Corporate Planning Development and Licensing. During his fourteen-year tenure at Sepracor Mr. Southwell advanced through a series of senior management positions with increasing responsibility in finance corporate planning development and licensing. Prior to joining Sepracor he was Vice President Investment Banking Division at Lehman Brothers in New York. Mr. Southwell graduated from Rice University and received his M.B.A. from the Tuck School of Business at Dartmouth College. He serves as Chairman of the Board of Directors of BioSphere Medical Inc. and is a member of the Board of Directors of PTC Therapeutics Inc. Mr. Southwell also serves as Chairman of the Tuck School of Business MBA Advisory Board and is a member of the Tuck School of Business Investing for Excellence Capital Campaign Steering Committee. | 